TotalMarketCap

Johnson & Johnson

JNJNYSE United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$656.305 B

$272.63 -1.33%

Close of 6 Nov 2026

As of 6 Nov 2026, Johnson & Johnson (JNJ) has a market capitalization of $656.3B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$94.2B

#39 by revenue

Earnings

$26.8B

#15 by earnings

Shares outstanding

2,407,310,266

Latest filing cover page

P/E ratio

24.5

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #1Eli Lilly & CoLLY$1.29T
  2. #2Johnson & JohnsonJNJ$656.3B
  3. #3AbbVieABBV$510.3B
  4. #4Merck & Co.MRK$362.2B
  5. #5NovartisNVS$309.0B

What if Johnson & Johnson were worth as much as…

Open the what-if tool →

Gold $28.2T

$11,729.64

Per share 43.0× higher

Bitcoin $1.53T

$634.67

Per share 2.33× higher

Apple $5.02T

$2,083.56

Per share 7.64× higher

Or at a round number

$1.00T$2.00T$5.00T$10.0T

Where these numbers come from

Share counts and financials for Johnson & Johnson are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.